| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |